Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:09 AM
Ignite Modification Date:
2025-12-25 @ 1:09 AM
NCT ID:
NCT02631993
Eligibility Criteria:
Inclusion Criteria:
* Eligible patients received photochemotherapy (Ultraviolet radiation type A on skin photosensitized by oral 8-methoxypsoralen) for acute graft-versus-host disease (GVHD within 100-days after HSCT). Photochemotherapy may be given as primary or later aGVHD therapy.
Exclusion Criteria:
* Patients with aGVHD after booster doses of stem-cells or donor-lymphocyte-infusions are not included.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02631993
Study Brief:
Protocol Section:
NCT02631993